140 related articles for article (PubMed ID: 32337164)
1. Evaluating the effect of type 2 diabetes mellitus on CYP450 enzymes and P-gp activities, before and after glycemic control: A protocol for a case-control pharmacokinetic study.
Neyshaburinezhad N; Rouini M; Shirzad N; Esteghamati A; Nakhjavani M; Namazi S; Ardakani YH
MethodsX; 2020; 7():100853. PubMed ID: 32337164
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the impact of type 2 diabetes mellitus on CYP450 metabolic activities: protocol for a case-control pharmacokinetic study.
Gravel S; Chiasson JL; Dallaire S; Turgeon J; Michaud V
BMJ Open; 2018 Feb; 8(2):e020922. PubMed ID: 29439084
[TBL] [Abstract][Full Text] [Related]
3. Modulation of CYP450 Activities in Patients With Type 2 Diabetes.
Gravel S; Chiasson JL; Turgeon J; Grangeon A; Michaud V
Clin Pharmacol Ther; 2019 Dec; 106(6):1280-1289. PubMed ID: 31099895
[TBL] [Abstract][Full Text] [Related]
4. Effect of fermented red ginseng on cytochrome P450 and P-glycoprotein activity in healthy subjects, as evaluated using the cocktail approach.
Kim MG; Kim Y; Jeon JY; Kim DS
Br J Clin Pharmacol; 2016 Dec; 82(6):1580-1590. PubMed ID: 27495955
[TBL] [Abstract][Full Text] [Related]
5. Geneva cocktail for cytochrome p450 and P-glycoprotein activity assessment using dried blood spots.
Bosilkovska M; Samer CF; Déglon J; Rebsamen M; Staub C; Dayer P; Walder B; Desmeules JA; Daali Y
Clin Pharmacol Ther; 2014 Sep; 96(3):349-59. PubMed ID: 24722393
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a six-probe cocktail (caffeine, tolbutamide, omeprazole, dextromethorphan, midazolam, and digoxin) approach to estimate hepatic drug detoxification capability and dosage requirements after a single oral dosing in healthy Chinese volunteers.
Koo SH; Soon GH; Pruvost A; Benech H; Ang TL; Lee EJD; Ang DSW
Naunyn Schmiedebergs Arch Pharmacol; 2022 Jul; 395(7):815-826. PubMed ID: 35394133
[TBL] [Abstract][Full Text] [Related]
7. Traditional Herbal Formulas to as Treatments for Musculoskeletal Disorders: Their Inhibitory Effects on the Activities of Human Microsomal Cytochrome P450s and UDP-glucuronosyltransferases.
Jin SE; Seo CS; Shin HK; Ha H
Pharmacogn Mag; 2016; 12(48):241-252. PubMed ID: 27867264
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous LC-MS/MS quantification of P-glycoprotein and cytochrome P450 probe substrates and their metabolites in DBS and plasma.
Bosilkovska M; Déglon J; Samer C; Walder B; Desmeules J; Staub C; Daali Y
Bioanalysis; 2014 Jan; 6(2):151-64. PubMed ID: 24423593
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling Method.
Bosilkovska M; Samer C; Déglon J; Thomas A; Walder B; Desmeules J; Daali Y
Basic Clin Pharmacol Toxicol; 2016 Sep; 119(3):284-90. PubMed ID: 27009433
[TBL] [Abstract][Full Text] [Related]
10. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577
[TBL] [Abstract][Full Text] [Related]
11. Effect of Red Ginseng on cytochrome P450 and P-glycoprotein activities in healthy volunteers.
Kim DS; Kim Y; Jeon JY; Kim MG
J Ginseng Res; 2016 Oct; 40(4):375-381. PubMed ID: 27746690
[TBL] [Abstract][Full Text] [Related]
12. Drug interaction potential of high-dose rifampicin in patients with pulmonary tuberculosis.
Stemkens R; Jager Vd; Dawson R; Diacon AH; Narunsky K; Padayachee SD; Boeree MJ; van Beek SW; Colbers A; Coenen MJH; Svensson EM; Fuhr U; Phillips PPJ; Te Brake LHM; Aarnoutse RE;
Antimicrob Agents Chemother; 2023 Oct; 67(10):e0068323. PubMed ID: 37768317
[TBL] [Abstract][Full Text] [Related]
13. Effect of ademetionine on cytochrome P450 isoforms activity in rats.
Tong S; Guo J; Song H; Lv S; Zhu Y; Ma J; Zheng Y
Int J Clin Exp Med; 2015; 8(6):9716-22. PubMed ID: 26309647
[TBL] [Abstract][Full Text] [Related]
14. Effects of suberoylanilide hydroxamic acid on rat cytochrome P450 enzyme activities.
Lin K; Zhang Q; Liu Z; Yang S; Lin Y; Wen C; Zheng Y
Int J Clin Exp Pathol; 2015; 8(5):5584-90. PubMed ID: 26191268
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Herb-Drug Interaction of Synacinn™ and Individual Biomarker through Cytochrome 450 Inhibition Assay.
Ab Rahman NS; Abd Majid FA; Abd Wahid ME; Zainudin AN; Zainol SN; Ismail HF; Wong TS; Tiwari NK; Giri S; Bhargava V
Drug Metab Lett; 2018; 12(1):62-67. PubMed ID: 29542427
[TBL] [Abstract][Full Text] [Related]
16. Multiplex Phenotyping for Systems Medicine: A One-Point Optimized Practical Sampling Strategy for Simultaneous Estimation of CYP1A2, CYP2C9, CYP2C19, and CYP2D6 Activities Using a Cocktail Approach.
de Andrés F; Terán S; Bovera M; Fariñas H; Terán E; LLerena A
OMICS; 2016 Feb; 20(2):88-96. PubMed ID: 26600202
[TBL] [Abstract][Full Text] [Related]
17. Phenotyping Indices of CYP450 and P-Glycoprotein in Human Volunteers and in Patients Treated with Painkillers or Psychotropic Drugs.
Darnaud L; Delage C; Daali Y; Trouvin AP; Perrot S; Khoudour N; Merise N; Labat L; Etain B; Bellivier F; Lloret-Linares C; Bloch V; Curis E; Declèves X
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986840
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the effect of ketamine on cytochrome P450 isoforms activity in rats by cocktail method.
Lin F; He Y; Zhang L; Zhang M; Zhang Y; Wen C
Int J Clin Exp Med; 2015; 8(3):4335-41. PubMed ID: 26064350
[TBL] [Abstract][Full Text] [Related]
19. Drug Interaction Potential of Osilodrostat (LCI699) Based on Its Effect on the Pharmacokinetics of Probe Drugs of Cytochrome P450 Enzymes in Healthy Adults.
Armani S; Ting L; Sauter N; Darstein C; Tripathi AP; Wang L; Zhu B; Gu H; Chun DY; Einolf HJ; Kulkarni S
Clin Drug Investig; 2017 May; 37(5):465-472. PubMed ID: 28155129
[TBL] [Abstract][Full Text] [Related]
20. Assessment of interaction potential of AZD2066 using in vitro metabolism tools, physiologically based pharmacokinetic modelling and in vivo cocktail data.
Nordmark A; Andersson A; Baranczewski P; Wanag E; Ståhle L
Eur J Clin Pharmacol; 2014 Feb; 70(2):167-78. PubMed ID: 24186263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
